Table 1.
Baseline characteristics of the patients included in the study.
| Control (n = 36) | NPDR-DMO (n = 18) | PDR-DMO (n = 19) | p value | |
|---|---|---|---|---|
| Age, years | 53.3 ± 14.19 CI 95% (11.51 to 18.51) |
61 ± 8.57 CI 95% (6.43 to 12.85) |
57.8 ± 9.56 CI 95% (7.23 to 14.14) |
0.151 |
| Gender (F/M) | 20 (55.6%)/16 (44.4%) | 9 (50%)/9 (50%) | 13 (68.4%)/6 (31.6%) | 0.497 |
| BCVA, letters | 83.75 ± 2.50 CI 95% (2.03 to 3.26) |
55.52 ± 24.46 CI 95% (18.22 to 37.23) |
45.94 ± 27.57 CI 95% (20.83 to 40.77) |
<0.00001 |
∗The results are expressed as mean ± SD or frequency with percentages in parentheses. N: number; F: female; M: male; BCVA: best-corrected visual acuity; NPDR-DMO: nonproliferative diabetic retinopathy-diabetic macular oedema; PDR-DMO: proliferative diabetic retinopathy-diabetic macular oedema.